scholarly article | Q13442814 |
P50 | author | Mohammad-Reza Zarrindast | Q10858140 |
P2093 | author name string | Mohammad Reza Zarrindast | |
Mohammad Nasehi | |||
Majid Navaeian | |||
P2860 | cites work | A synaptic model of memory: long-term potentiation in the hippocampus | Q22337276 |
Cannabinoid receptor localization in brain | Q24558751 | ||
The endocannabinoid system as an emerging target of pharmacotherapy | Q24648473 | ||
Cannabinoids, hippocampal function and memory | Q28142949 | ||
A six-factor structure of personality-descriptive adjectives: solutions from psycholexical studies in seven languages | Q28242859 | ||
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 | Q28270721 | ||
Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 | ||
Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens | Q28346456 | ||
mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis | Q28591542 | ||
Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 | ||
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens | Q30499463 | ||
Pharmacological and biochemical interactions between opioids and cannabinoids. | Q33677066 | ||
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. | Q33918606 | ||
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers | Q33955711 | ||
Requirement of a critical period of transcription for induction of a late phase of LTP. | Q34332490 | ||
Modulation of transmitter release via presynaptic cannabinoid receptors | Q34430714 | ||
Involvement of the endocannabinoid system in drug addiction | Q34495242 | ||
Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments--could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study | Q34589928 | ||
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
Functions of cannabinoid receptors in the hippocampus | Q34750566 | ||
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. | Q35214463 | ||
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders | Q35586641 | ||
Synergistic interactions between cannabinoid and opioid analgesics | Q35620905 | ||
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs | Q35690551 | ||
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms. | Q37414652 | ||
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. | Q40460540 | ||
Correlation between the Pharmacology of Long-Term Potentiation and the Pharmacology of Memory | Q40476305 | ||
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism | Q40817229 | ||
Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides | Q41041826 | ||
Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. | Q42507328 | ||
Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia | Q42608588 | ||
Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. | Q42610048 | ||
Morphine-induced impairment of spatial memory acquisition reversed by morphine sensitization in rats. | Q43131006 | ||
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor | Q43503403 | ||
Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. | Q44012260 | ||
Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference | Q44090407 | ||
Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms | Q44133908 | ||
The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. | Q44141102 | ||
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor | Q44303656 | ||
Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. | Q44334367 | ||
Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice | Q44335154 | ||
CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn | Q44337088 | ||
Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity | Q44337241 | ||
Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. | Q44340144 | ||
Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. | Q44342434 | ||
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens | Q44345871 | ||
The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment | Q44347164 | ||
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats | Q44875762 | ||
Morphine state-dependent learning: sensitization and interactions with dopamine receptors. | Q45014977 | ||
Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats | Q45082866 | ||
Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. | Q46007120 | ||
Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference | Q46379090 | ||
Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats | Q46507482 | ||
The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice. | Q46713317 | ||
Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference. | Q46940274 | ||
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. | Q48104366 | ||
Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization | Q48325216 | ||
Influence of morphine- or apomorphine-induced sensitization on histamine state-dependent learning in the step-down passive avoidance test | Q48553680 | ||
Social support and personal models of diabetes as predictors of self-care and well-being: a longitudinal study of adolescents with diabetes. | Q51080798 | ||
Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. | Q51575344 | ||
Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. | Q51609461 | ||
Morphine withdrawal modifies antinociceptive effects of acute morphine in rats. | Q51981915 | ||
Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents. | Q51983082 | ||
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | Q52060269 | ||
The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. | Q52167130 | ||
The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. | Q52210105 | ||
Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents. | Q52290975 | ||
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity | Q64386018 | ||
Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress | Q73367937 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cannabinoids | Q422936 |
P304 | page(s) | 51-59 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Neuroscience Research | Q15764280 |
P1476 | title | Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats | |
P478 | volume | 69 |
Q36453850 | Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands |
Q36568744 | Effects of Estrogen Receptor Modulators on Morphine Induced Sensitization in Mice Memory |
Q89894276 | Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys |
Q39031134 | Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review |
Q37141169 | Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice |
Q39459073 | Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder |
Q48123708 | Preconditioning with morphine protects hippocampal CA1 neurons from ischemia-reperfusion injury via activation of the mTOR pathway |
Q47410020 | Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine |
Q41436243 | Subregional Structural Alterations in Hippocampus and Nucleus Accumbens Correlate with the Clinical Impairment in Patients with Alzheimer's Disease Clinical Spectrum: Parallel Combining Volume and Vertex-Based Approach |
Q44128178 | Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice |
Search more.